Concepedia
Journal of the American Academy of Dermatology · 2013 · 34 citations · 3 references
MedicineOncologyPathologyImmunotherapyMolecular OncologyNeoplasiaMalignant NeoplasmsMerkel Cell CarcinomaClinical RemissionHistologic RemissionMerkel Cell Carcinoma ImmunotherapyMerkel Cell Carcinoma Therapy
3
Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.
Michelle J. Frost, Petranel T. Ferrão, Timothy P. Hughes et al. · PubMed · 2002 · 252 citations
Medicine, Molecular Biology, Oncology +15
A Phase II Trial of Imatinib Mesylate in Merkel Cell Carcinoma (Neuroendocrine Carcinoma of the Skin)
Wolfram E. Samlowski, James Moon, Ralph J. Tuthill et al. · American Journal of Clinical Oncology · 2010 · 86 citations · Full text
Medicine, Dermatology, Oncology +16
Response to a Novel Multitargeted Tyrosine Kinase Inhibitor Pazopanib in Metastatic Merkel Cell Carcinoma
Matthew S. Davids, Amanda Charlton, Swee-Siang Ng et al. · Journal of Clinical Oncology · 2009 · 81 citations
Medicine, Oncology, Pharmacology +12